Five-Year Efficacy and Safety of Asfotase Alfa Therapy for Adults and Adolescents with Hypophosphatasia
To read more please click on the link below.
Read Article
Related Articles
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Letter to the Editor: “Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study”
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Responses